Advertisement
Screener

ABSCI CORP (ABSI) Material Contracts

ABSCI CORP Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-05-07: Form 10-Q; Exhibit 10.1; Description Amended and Restated Non-Employee Director Compensation Policy, effective January 1, 2026..
  • 2026-03-06: Form 8-K; Exhibit 10.2; Description Form of Officer Indemnification Agreement, as adopted on March 6, 2026.
  • 2026-03-06: Form 8-K; Exhibit 10.1; Description Form of Director Indemnification Agreement, as adopted on March 6, 2026.
  • 2025-11-04: Form 8-K; Exhibit 10.1; Description absci-totientsideletterxre.htm.
FiledFormExhibitDescription
2026-05-0710-Q10.1Amended and Restated Non-Employee Director Compensation Policy, effective January 1, 2026.
2026-03-068-K10.2Form of Officer Indemnification Agreement, as adopted on March 6, 2026
2026-03-068-K10.1Form of Director Indemnification Agreement, as adopted on March 6, 2026
2025-11-048-K10.1absci-totientsideletterxre.htm
2024-08-1410-Q10.2Employment Agreement, by and between Absci Corporation and Shelby Walker, dated June 27, 2024.
2024-08-1410-Q10.12021 Stock Option and Incentive Plan and forms of award agreements thereunder.
2024-05-1410-Q10.1Amended and Restated Non-Employee Director Compensation Policy.
2024-03-2110-K10.42023 Inducement Plan and forms of award agreements thereunder.
2024-03-2110-K10.22021 Stock Option and Incentive Plan and forms of award agreements thereunder.
2023-11-1410-Q10.4Separation Agreement, by and between Absci Corporation and Sarah Korman, dated August 16, 2023.
2023-11-1410-Q10.3Transition Agreement, by and between Absci Corporation and Gregory Schiffman, dated August 14, 2023.
2023-11-1410-Q10.2Employment Agreement, by and between Absci Corporation and Zachariah Jonasson, dated August 31, 2023.
2023-11-1410-Q10.1Offer Letter, by and between Absci Corporation and Zachariah Jonasson, dated August 12, 2023.
2023-08-1410-Q10.1Employment Agreement, by and between Absci GmbH and Andreas Busch, dated as of September 30, 2022.
2022-11-0910-Q10.3Consulting Agreement by and between the Company and Matthew Weinstock dated October 4, 2022.
2022-11-0910-Q10.2Separation Agreement by and between the Company and Matthew Weinstock dated September 30, 2022.
2022-11-0910-Q10.12021 Stock Option and Incentive Plan and forms of award agreements thereunder.
2022-03-2210-K10.11Employment Agreement, by and between the Registrant and Nikhil Goel, dated as of July 26, 2021.
2022-03-2210-K10.10Employment Agreement, by and between the Registrant and Sarah Korman, dated as of July 26, 2021.
2022-03-2210-K10.9Employment Agreement, by and between the Registrant and Matthew Weinstock, dated as of July 26, 2021.
2021-09-0710-Q10.7Employment Agreement, by and between the Registrant and Gregory Schiffman, dated as of July 26, 2021.

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14